JPMORGAN CHASE & CO - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 82 filers reported holding XENON PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,718,146
-43.7%
50,297
-36.5%
0.00%
Q2 2023$3,049,856
+160.0%
79,217
+141.6%
0.00%
Q1 2023$1,173,000
+1430387.8%
32,787
+1471.0%
0.00%
Q4 2022$82
-99.9%
2,087
-51.1%
0.00%
Q3 2022$155,000
+109.5%
4,271
+74.6%
0.00%
Q2 2022$74,000
-61.9%
2,446
-61.6%
0.00%
Q1 2022$194,000
+30.2%
6,371
+33.4%
0.00%
Q4 2021$149,000
+223.9%
4,775
+58.4%
0.00%
Q3 2021$46,000
+21.1%
3,014
+47.8%
0.00%
Q2 2021$38,000
-67.2%
2,039
-68.7%
0.00%
Q1 2021$116,000
+11500.0%
6,505
+11115.5%
0.00%
Q4 2020$1,000
-99.9%
58
-99.9%
0.00%
Q2 2020$1,208,000
+112.7%
96,372
+92.3%
0.00%
Q1 2020$568,000
-26.0%
50,119
-14.5%
0.00%
Q4 2019$768,000
+304.2%
58,593
+177.3%
0.00%
Q3 2019$190,000
-42.8%
21,132
-37.1%
0.00%
Q2 2019$332,000
-66.1%
33,594
-65.2%
0.00%
Q1 2019$979,000
-18.2%
96,404
-49.2%
0.00%
Q4 2018$1,197,000
+978.4%
189,811
+2151.6%
0.00%
Q3 2018$111,000
+311.1%
8,430
-8.6%
0.00%
Q3 2017$27,000
-20.6%
9,226
-14.7%
0.00%
Q2 2017$34,000
+142.9%
10,816
+199.1%
0.00%
Q1 2017$14,0000.0%3,616
+112.7%
0.00%
Q3 2016$14,000
+1300.0%
1,700
+1431.5%
0.00%
Q2 2016$1,0001110.00%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 850,000$15,215,0003.58%
ACUTA CAPITAL PARTNERS, LLC 412,500$7,384,0002.66%
BVF INC/IL 3,481,778$62,324,0002.34%
Soleus Capital Management, L.P. 708,117$12,675,0002.28%
COMMODORE CAPITAL LP 301,392$5,395,0002.15%
DAFNA Capital Management LLC 406,535$7,277,0001.73%
Parkman Healthcare Partners LLC 374,395$6,702,0001.56%
Avoro Capital Advisors LLC 3,650,000$65,335,0001.13%
KNOTT DAVID M 144,101$2,579,0001.10%
Orbimed Advisors 2,497,917$44,713,0000.42%
View complete list of XENON PHARMACEUTICALS INC shareholders